In 2022, Manny Simons sold his company to Eli Lilly. Now, as managing director for the pharmaceutical giant in Australia and New Zealand, he is fighting to secure a PBS listing. | Collector
Financial Review
In 2022, Manny Simons sold his company to Eli Lilly. Now, as managing director for the pharmaceutical giant in Australia and New Zealand, he is fighting to secure a PBS listing.
In 2022, Manny Simons sold his company to Eli Lilly. Now, as managing director for the pharmaceutical giant in Australia and New Zealand, he is fighting to secure a PBS listing.
Financial Review